Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non–Small-Cell Lung Cancer

PURPOSE: A prior study demonstrated that addition of continuous daily erlotinib fails to improve response rate or survival in non–small-cell lung cancer (NSCLC) patients treated with carboplatin and paclitaxel. However, preclinical data support the hypothesis that intermittent administration of erlo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riely, Gregory J., Rizvi, Naiyer A., Kris, Mark G., Milton, Daniel T., Solit, David B., Rosen, Neal, Senturk, Emir, Azzoli, Christopher G., Brahmer, Julie R., Sirotnak, Francis M., Seshan, Venkatraman E., Fogle, Margaret, Ginsberg, Michelle, Miller, Vincent A., Rudin, Charles M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Thoracic Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645610/
https://ncbi.nlm.nih.gov/pubmed/19047285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.4656
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados